Screener
Palisade Bio, Inc. PALI Q3 2025 earnings
Reported November 10, 2025 · Before market open
EPS-$0.38Miss by $0.06
EPS estimate-$0.32
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$465.3K
EPS estimate-$0.06
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Palisade Bio, Inc. report Q3 2025 earnings?
- Palisade Bio, Inc. (PALI) reported Q3 2025 earnings on November 10, 2025 before market open.
- What were Palisade Bio, Inc.'s Q3 2025 revenue and EPS?
- Palisade Bio, Inc. reported eps of $-0.38 for Q3 2025.
- Did Palisade Bio, Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.32 by $0.06.
- How did Palisade Bio, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 83.6% from $-2.32.
- Where can I find Palisade Bio, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-274262) directly on SEC EDGAR. The filing index links above go to sec.gov.
